Diabetes (type 2) treatment doubles in 6 years

by ARTiFactor on Nov. 09th, 2008

The annual cost of treating adult cases of diabetes in the United States nearly doubled between 2001 and 2007.

"Just because a drug is new or exploits a new mechanism does not mean that it adds clinically to treating particular diseases," said co-author Randall Stafford, MD, PhD, associate professor at Stanford University School of Medicine in California. "And even if a new drug does have a benefit, it's important to consider whether that benefit is in proportion to the increased cost."

Read more about Randall Stafford's article in the Oct. 27 issue of the Archives of Internal Medicine: Costlier new diabetes drugs do not necessarily produce better outcomes

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <a> <h3> <h4> <em> <i> <strong> <b> <span> <ul> <ol> <li> <blockquote> <object> <embed> <param> <sub> <sup>
  • Lines and paragraphs break automatically.
  • You may embed videos from the following providers vimeo, youtube. Just add the video URL to your textarea in the place where you would like the video to appear, i.e. http://www.youtube.com/watch?v=pw0jmvdh.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Images can be added to this post.

More information about formatting options